myelogenous
myelogenous
1. Expression of bcl-2 gene in the evolution of chronic myelogenous leukemia to blast crisis and its implication
bcl-2基因表达在慢性粒细胞白血病急变中的意义
2. Association of Cell Growth Modalities in vitro with Its Heterogenous Expression of BCL-XL in Relapsed Acute Myelogenous Leukemic Cells
BCL-XL异质性表达与复发急性髓性白血病细胞体外生长类型的关系
3. Effects of bcr/abl mRNA Antisense Oligonucleotides on Ph Positive Chronic Myelogenous Leukemia Cells
bcr/abl mRNA反义寡核苷酸对慢性粒细胞白血病Ph~+细胞的作用
4. CNL was a rare clinicopathologic entity that could distinguished from chronic myelogenous leukemia.
CNL是一种少见类型的慢性白血病 ,其特点与慢性髓细胞白血病不同 ;
5. DNA repair enzyme inhibitors , which are derived from toxins found in certain plants, can cause acute myelogenous leukemia and myelodysplastic syndromes.
DNA修复酶抑制剂，取自某些植物的毒素，可导致急性髓细胞白血病和骨髓增生异常综合征。
6. HLA allele polymorphism associated with susceptibility of chronic myelogenous leukemia and acute lymphoblastic leukemia
HLA基因多态性与慢性粒细胞和急性淋巴细胞白血病易感性的关联分析
7. Immuno-biotherapy with DLI +IL-2 after Mixed-HSCT in patients of acute myelogenous leukemia may be a method to increase DFS efficiently.
Mixed-HSCT后应用DLI+IL-2,可能是有效提高长期生存率的免疫生物治疗措施之一。
8. EXPRESSION OF nm23-H_1 MRNA IN CHRONIC MYELOGENOUS LEUKEMIA(CML)
nm23-H_1基因在慢性粒细胞白血病中表达的研究
9. The bcr/abl gene has been documented as having a significant role to play in the pathogenesis of Ph+ chronic myelogenous leukemia (CML).
Ph~+慢性粒细胞白血病(CML)的bcr/abl融合基因在其发病机制中具有重要作用。
10. Detection of bcr/abl fusion gene in chronic myelogenous leukemia by single step reverse transcription polymerase chain reaction
RT-PCR一步法检测慢性粒细胞白血病bcr/abl融合基因
11. pseudoleukemia myelogenous
[医] 骨髓性假白血病
12. myelogenous leucocythemia
[医] 骨髓性白血病
13. “Acute lymphocytic leukemia” and “acute myelogenous leukemia” are each composed of young cells, known as “lymphoblasts” or “myeloblasts.
“急性淋巴细胞性白血病”和“急性髓细胞性白血病”各由不同的幼稚细胞如“成淋巴细胞”或“成髓细胞”组成。
14. “Acute lymphocytic leukemia” and “acute myelogenous leukemia” are each composed of young cells, known as “lymphoblasts” or “myeloblasts.” These cells are sometimes called “blasts.
“急性淋巴细胞性白血病”和“急性髓细胞性白血病”各由不同的幼稚细胞如“成淋巴细胞”或“成髓细胞”组成，有时也称为“母细胞”。
15. “Chronic” leukemias have few or no blast cells. “Chronic lymphocytic leukemia” and “chronic myelogenous leukemia” usually progress slowly compared to acute leukemias.
“慢性”白血病少有或几乎没有母细胞。与急性白血病相比，“慢性淋巴细胞白血病”、“慢性髓细胞白血病”的进程通常较为缓慢。
16. Procarbazine, nitrogen mustard, and ifosfamide, which can increase risk for myelodysplastic syndromes and acute myelogenous leukemia.
丙卡巴肼、氮芥和异环磷酰胺：可增加患骨髓增生异常综合症和急性粒细胞白血病的风险。
17. Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr/abl fusion gene
两例Ph染色体阳性慢性粒细胞白血病患者具有少见型bcr/abl融合基因
18. Subacute myelogenous leukemia
亚急性骨髓性白血病
19. human chronic myelogenous leukemia cell line
人慢粒细胞系
20. Bcr/Abl-based Novel Therapeutic Strategies in Chronic Myelogenous Leukemia Treatment
以Bcr/Abl为靶标治疗慢性骨髓性白血病的策略研究
21. The drug Gleevec, for example, was designed to inhibit an enzyme produced by a mutant fused version of two genes, called BCR-ABL, that causes chronic myelogenous leukemia.
以基利克（Gleevec）这个药物为例。基利克的设计是用来抑制某个造成慢性骨髓性白血症的酵素活性；该酵素是由BCR-ABL这两个基因混合而成的突变版本所生成。
22. The proliferative potential index(PPI) of bone marrow cells was detected by premature chromosome condensation(PCC) methods in 17 patients with chronic myelogenous leukemia(CML) and 8 healthy subjects.
以期前凝集染色体（PCC）技术测定17例慢性粒细胞白血病（CML）和8例正常对照者骨髓细胞增殖潜能指数（PPI）。
23. hypoplastic acute myelogenous leukemia
低增生性急性髓细胞性白血病
24. In sharp contrast, all transforming Abl variants are exclusively cytoplasmic, such as Bcr-Abl, even though which contains same NLS and NES sequence as c-Abl. It is critical in inducing human chronic myelogenous leckemia (CML).
例如BCR-Abl,虽然它具有与c-Abl相同的C端序列和NLS、NES,但它只存在于胞质中,而且胞质中BCR-Abl的组成型活化是导致人类慢性粒细胞白血病(CML)的重要原因。
25. Keywords chronic myelogenous leukemia;bone marrow;mesenchymal stem cells;cell differentiation;neuron-like cells;
关键词慢性粒细胞性白血病;骨髓;间充质干细胞;细胞分化;神经元样细胞;
26. Keywords calcium ionophore;dendritic cells;chronic myelogenous leukemia;
关键词树突状细胞;钙载体;慢性髓性白血病;
27. Title： Effects of Camptothecin,Amsacrine and Vinblastine on the cell cycle of lymphocytic or myelogenous leukemia cells.
关键词：喜树碱;胺苯吖啶;长春花碱;细胞周期;脱噬作用
28. Title： Proliferation of reticulin fibre and megakaryocyte in bone marr ow of Guangix,patients with chronic myelogenous leukemia.
关键词：慢性白血病；骨髓纤维化；网硬蛋白纤维；巨核细胞；骨髓活组织检查
29. myelogenous callus
内骨痂, 骨髓骨痂, 骨髓原性骨痂
30. Identification of apoptosis of myeloblasts and erythroblasts in situ in patients with Myelodysplastic Syndromes, Chronic Aplasia, Acute Myelogenous Leukemia, Megaloblastic Anemia and Hemolytic Anemia
原位检测骨髓粒、红两系凋亡率对骨髓增生异常综合征的诊断意义
31. Effects of Camptothecin, Amsacrine and Vinblastine on the cell cycle of lymphocytic or myelogenous leukemia cells.
喜树碱、胺苯吖啶、长春花碱对淋巴细胞性和髓样白血病细胞周期的影响。
32. In acute myelogenous leukemia (AML) and acute lymphocytic leukemia (ALL), the original acute leukemia cell goes on to form about a trillion more leukemia cells.
在急性髓细胞性白血病AML和急性淋巴细胞性白血病ALL中，原始的急性白血病细胞进展、形成多达上亿个的白血病细胞。
33. 3.In patients with chronic myelogenous leukemia one sees an odd chromosome in all of the cancerous cells.
在慢性粒细胞白血病的患者中，可以发现所有的癌细胞都有同一个奇怪的染色体。
34. In chronic myelogenous leukemia, a malignant tumor of myeloid stem cells, all cells possess a distinctive (nonrandom) translocation referred to as Philadelphia chromosome.
在慢性髓细胞性白血病，一种髓性干细胞的恶性肿瘤，其所有肿瘤细胞拥有一个特征性的染色体的易位，所涉及的染色体称为费城染色体。
35. In chronic myelogenous leukemia (CML), the leukemia cell that starts the disease makes blood cells (red cells, white cells and platelets) that function almost like normal cells.
在慢粒中，起病的白血病细胞能产生功能上近乎正常的血细胞（红细胞、白细胞、血小板）。
36. At high power, the bone marrow of a patient with acute myelogenous leukemia is seen here. There is one lone megakaryocyte at the right center.
在高倍镜下,见到的是急性髓母细胞白血病骨髓。在右侧中心处有一个孤立巨核细胞。
37. At high power, the bone marrow of a patient with acute myelogenous leukemia is seen here.
在高倍镜下，见到的是急性髓母细胞白血病骨髓。
38. LONG- TERM OUTCOME OF HEGH- DOSE CYTARABINE- BASED CONSOLIDATION CHEMOTHERAPY FOR CHILDHOOD WITH ACUTE MYELOGENOUS LEUKEMIA
大剂量阿糖胞苷治疗儿童急性髓细胞性白血病的远期疗效
39. It is approved for the treatment of chronic myelogenous leukemia (CML) and hairy cell leukemia.
它被批准用于慢性髓细胞白血病和毛细胞白血病的治疗。
40. Keywords Real Time Quantitative PCR;chronic myelogenous leukemia;imatinib mesylate;BCR-ABL fusion gene;resistance mechanism;
实时定量PCR;慢性髓细胞白血病;伊马替尼;BCR-ABL融合基因;耐药机制;
41. No bcr/abl gene was revealed in the controls, while in the chronic myelogenous leukemia(CML) group the positive rate was 89.5%(17/19).
对照组bcr/abl基因表达均为阴性。 慢性粒细胞白血病 (CML)病人bcr/abl基因表达阳性率为 89.5% (1 7/ 1 9) ,经治疗达临床缓解者 8例 ,bcr/abl基因表达均值为 (2 .4 3± 0 .6 7)× 1 0 5基因拷贝 /L ;
42. Clinical observation on the effects of low dosage imatinib to chronic myelogenous leukemia in blast crisis
小剂量伊马替尼治疗慢性髓细胞白血病急变期患者的临床疗效
43. Evaluation of clinical effectiveness of combination therapy with interferon-alpha and hydroxyurea in patients witl chronic myelogenous leukemia
干扰素合并羟基脲治疗慢性粒细胞性白血病的疗效探讨
44. Effect of interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemia
干扰素对慢性髓细胞白血病骨髓纤维化的治疗效应
45. juvenile chronic myelogenous leukemia
幼年型慢性粒细胞白血病
46. Keywords sequence-tagged site;single nucleotide polymorphism;denaturing high performance liquid chromatography;DNA pooling;chronic myelogenous leukemia;
序列标签位点;单核苷酸多态性;变性高效液相色谱;DNA池;慢性髓细胞性白血病;
47. Detection of the AML1/ETO fusion transcript in acute myelogenous leukemia type M2 by RT/PCR
应用RT/PCR技术检测急性粒细胞白血病M2型AML1/ETO融合基因转录本的研究
48. Genetic instability of microsatellites Mfd41 and DCC in the evolution of chronic myelogenous leukemia
微卫星Mfd41和DCC的遗传不稳定性与慢性粒细胞白血病病程发展关系研究
49. Acute myelogenous leukemia
急性骨髓性白血病
50. Acute myelogenous leukemia (AML) is a cancer of the bone marrow that makes new blood cells and it develops as a result of DNA mutations that accumulate as a person grows older.
急性骨髓性白血病(AML)是造血系统骨髓瘤的一种，随着患者年龄的增长，这种肿瘤将逐渐发展累计导致基因的突变。
51. Acute myelogenous leukemia without maturation
急性骨髓性细胞白血病不伴成熟
52. Acute myelogenous leukemia with maturation
急性骨髓性细胞白血病伴成熟
53. Keywords Acute myelogenous leukemia Chemotherapy Complication;
急性髓性白血病;化疗;并发症;
54. Acute myelogenous leukemia (AML)
急性髓系白血病
55. Keywords acute myelogenous leukemia;vascular endothelial growth factor（VEGF）;soluble epicyte cadherin（SE-CAD）;
急性髓系白血病;血管内皮生长因子;可溶性上皮型钙黏蛋白;
56. Acute myelogenous leukemia concurrent with chronic lymphocytic leukemia one case report and review literature
急性髓系白血病合并慢性淋巴细胞白血病一例报道及文献复习
57. Progress in the Studies of Acute Myelogenous Leukemia Stem Cell--Review
急性髓系白血病干细胞的研究进展
58. Clinical Significance of Determination of Changes of Serum VEGF and SE-CAD Levels After Treatment in Patients with Acute Myelogenous Leukemia(AML)
急性髓系白血病患者治疗前后血清VEGF和SE-CAD检测的临床意义
59. Relationship between the expression of bcl-2 apoptosis and acute myelogenous leukemia prognosis
急性髓系细胞白血病bcl-2表达水平与预后的关系
60. Acute myelogenous leukaemia
急性髓细胞性白血病
61. Detection of the AML1-ETO Fusion Transcript in Acute Myelogenous Leukemia Type M2
急性髓细胞白血病M2型AML1-ETO融合转录本的检测
62. PREDICATIVE DIAGNOSIS OF EARLY DEATH IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
急性髓细胞白血病早期病死的预测诊断
63. leukemia chronic myelogenous
慢性粒细胞性白血病
64. The Study of the Correlation between the Polymorphism of HLA Alleles and Chronic Myelogenous Leukemia
慢性粒细胞性白血病与HLA等位基因多态性的相关性
65. Isolation and identification of chronic myelogenous leukemia bone marrow mesenchymal stem cells and their functional characteristics
慢性粒细胞性白血病骨髓间充质干细胞的分离纯化及其功能特性的研究
66. Chronic myelogenous leukaemia
慢性粒细胞白血病
67. Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disease of transformed hematopoietic progenitor cells.
慢性粒细胞白血病(chronic myelogcnous leukemia,CML)是一种以髓系细胞受累为主的多能造血干细胞的克隆性疾病。
68. Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disorder due to an acquired abnormality in a pluripotential hematopoietic stem cell.
慢性粒细胞白血病(Chronic Myelogenous Leukemia，CML，简称慢粒)是一种起源于多能干细胞异常克隆的恶性增殖性疾病。
69. Keywords chronic myelogenous leukemia;P53 gene;centrosome;K562 cells;adenovirus vector;
慢性粒细胞白血病;p53基因;中心体;K562细胞;腺病毒载体;
70. Analysis and Identification of Variant Ph Chromosome Translocation in Patients with Chronic Myelogenous Leukemia by Conventional Cytogenetics and Fluorescence in situ Hybridization
慢性粒细胞白血病患者Ph染色体变异易位的细胞遗传学特征与荧光原位杂交研究
71. Study of Chromosome Change in Chronic Myelogenous Leukemia in Blastic Crisis
慢性髓性白血病急性变时染色体变化的研究
72. Analysis of ABL tyrosine kinase point mutations in imatinib treated chronic myelogenous leukemia patients
慢性髓性白血病患者伊马替尼治疗后ABL激酶区点突变分析
73. Cloning and expression of chronic myelogenous leukemia bcr-abl fusion gene in COS-7 cells
慢性髓系白血病bcr-abl融合基因的克隆及其在COS-7细胞中的表达
74. chronic myelogenous leukemia
慢性髓细胞性白血病
75. Keywords chronic myelogenous leukemia （CML）;BCR/ABL fusion gene;eukaryotic expression vector;RNA interference;K562 cell line;
慢性髓细胞性白血病;BCR/ABL融合基因;真核细胞表达载体;RNA干扰;K562细胞株;
76. blastic crisis of chronic myelogenous leukemia
慢性髓细胞性白血病原始细胞危象
77. Keywords Chronic myelogenous leukemia;Blastic crisis;T lymphoblastie lymphoma/acute lymphobtastic leukemia;Case report;
慢性髓细胞白血病;急变;T淋巴细胞淋巴瘤/白血病;病例报告;
78. STUDY ON TRANSCRIPTION OF abl ONCOGENE IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
慢粒白血病abl癌基因表达的研究
79. chronic myelogenous leukemia cell line
慢粒细胞系
80. adult chronic myelogenous leukemia
成人型慢性粒细胞白血病
